Thomes Paul G, Brandon-Warner Elizabeth, Li Ting, Donohue Terrence M, Schrum Laura W
Department of Internal Medicine, Carolinas Medical Center, Charlotte, NC, USA.
Department of Internal Medicine, Carolinas Medical Center, Charlotte, NC, USA.
Int J Biochem Cell Biol. 2016 Dec;81(Pt A):137-147. doi: 10.1016/j.biocel.2016.11.007. Epub 2016 Nov 10.
We demonstrated that ligand-activated nuclear receptor Rev-erbα mitigates CCl-induced liver fibrosis. Rev-erbα is also a novel regulator of autophagy, a crucial eukaryotic catabolic system in which lysosomes degrade substrates for energy generation. In hepatic stellate cells (HSC) autophagy is reportedly required for this purpose to activate HSCs during fibrogenesis. Here, we examined whether pharmacological activation of Rev-erb with its synthetic ligand SR9009 or treatment with the pro-fibrotic cytokine, TGF-β, each differentially modulate autophagy to regulate the HSC phenotype. We measured the effects of SR9009 on autophagy markers in a CCl-induced liver fibrosis model. Using primary and immortalized HSCs in vitro, we quantified SR9009 and TGF-β effects on autophagy flux. Compared with vehicle-treated controls, livers from CCl-treated mice exhibited lower AMPK, higher P70S6K phosphorylation, elevated P62 and lower levels of ATG proteins, indicating a disruption of autophagosome (AV) formation. SR9009 treatment prevented CCl-induced P70S6K phosphorylation but did not affect CCl-induced changes in AMPK, ATG proteins or P62. Analysis of autophagy markers and autophagy flux in primary HSCs or an immortalized human HSC line (LX2), revealed that SR9009 exposure down-regulated AV biogenesis. These events were associated with lower levels of fibrogenic gene expression, P70S6K phosphorylation and HSC proliferation. However, HSC exposure to TGF-β enhanced fibrogenic gene expression, P70S6K phosphorylation and HSC proliferation, while it simultaneously decelerated AV synthesis. The autophagy activator rapamycin and the autophagy inhibitor wortmannin each decreased HSC activation, P70S6K phosphorylation and HSC proliferation. Furthermore, knock-down of P70S6K using siRNA blocked basal and TGF-β-induced cell proliferation in human activated LX2. We conclude that SR9009 and TGF-β both similarly affected autophagy but, differentially regulated HSC fibrogenic phenotype through modulation of P70S6K, which is crucial for cell proliferation and fibrogenesis.
我们证明配体激活的核受体Rev-erbα可减轻四氯化碳诱导的肝纤维化。Rev-erbα也是自噬的一种新型调节因子,自噬是一种关键的真核分解代谢系统,其中溶酶体降解底物以产生能量。据报道,在肝星状细胞(HSC)中,自噬是肝纤维化形成过程中激活HSC所必需的。在此,我们研究了用其合成配体SR9009对Rev-erb进行药理学激活或用促纤维化细胞因子TGF-β处理,是否会分别以不同方式调节自噬来调控HSC表型。我们在四氯化碳诱导的肝纤维化模型中测量了SR9009对自噬标志物的影响。利用原代和永生化的HSC进行体外实验,我们量化了SR9009和TGF-β对自噬通量的影响。与用赋形剂处理的对照组相比,四氯化碳处理的小鼠肝脏中AMPK水平较低,P70S6K磷酸化水平较高,P62升高,ATG蛋白水平较低,表明自噬体(AV)形成受到破坏。SR9009处理可防止四氯化碳诱导的P70S6K磷酸化,但不影响四氯化碳诱导的AMPK、ATG蛋白或P62的变化。对原代HSC或永生化人HSC系(LX2)中的自噬标志物和自噬通量进行分析,结果显示暴露于SR9009会下调AV生物合成。这些事件与纤维化基因表达水平降低、P70S6K磷酸化和HSC增殖减少有关。然而,HSC暴露于TGF-β会增强纤维化基因表达、P70S6K磷酸化和HSC增殖,同时会减缓AV合成。自噬激活剂雷帕霉素和自噬抑制剂渥曼青霉素均可降低HSC激活、P70S6K磷酸化和HSC增殖。此外,使用小干扰RNA敲低P70S6K可阻断人活化LX2中的基础和TGF-β诱导的细胞增殖。我们得出结论,SR9009和TGF-β对自噬的影响相似,但通过调节对细胞增殖和纤维化至关重要的P70S6K,以不同方式调控HSC纤维化表型。